Clintrax Global, Inc.

clintraxglobal.com

Clintrax Global provides Investigator Agreement negotiation and payment services for Clinical Research Organizations and Pharmaceutical companies worldwide. We specialize in short contract cycle times with comprehensive legal review. We have the ability to service large, global investigator contract FSP work in addition to one-off CRO study rescue.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

ABCELLERA AND EVEREST MEDICINES ANNOUNCE MULTI-TARGET COLLABORATION TO ADVANCE NEW ANTIBODY THERAPIES

Everest Medicines | September 23, 2021

news image

AbCellera and Everest Medicines Limited announced that they have entered into a multi-year collaboration and license agreement to discover therapeutic antibodies for up to 10 targets selected by Everest. The partnership will help to expand Everest’s portfolio of novel medicines across multiple indications, with the initial programs focusing on targets in oncology. We are proud to partner with Everest as they build a robust pipeline of innovative medicines for p...

Read More

Pharma Tech

IKTOS ANNOUNCES DEPLOYMENT OF THEIR AI FOR DRUG DESIGN SOFTWARE MAKYA™ BY CHIESI GROUP

Iktos and Chiesi Group | December 03, 2021

news image

ktos, a company specialized in Artificial Intelligence for new drug design today announced collaboration agreement in AI for new drug design with Chiesi Group, the international research-focused pharmaceutical and healthcare. Under the agreement, Iktos’s de novo generative design software Makya™ will be used by Chiesi scientists to facilitate rapid and cost-effective design of novel compounds and accelerate hit-to-lead/lead optimisation for undisclosed Chiesi’s drug discovery p...

Read More

CLARUS EQUIPS TOP PHARMACEUTICAL COMPANY, ASTRAZENECA, WITH INNOVATIVE THERMOBILE BOARDS IN THE FIGHT AGAINST COVID-19

Clarus | April 22, 2020

news image

Clarus, the industry leader in glassboard innovation and creator of the new TherMobile, a non-porous mobile board that serves as a protective shield during the health screening process, is successfully supporting AstraZeneca's efforts in keeping their essential employees safe while continuing to work during the COVID-19 crisis. "We initially developed TherMobile as a way to keep our own employees safe while implementing employee temperature screening at our facility," said Marc Man...

Read More

TEMPERATURE CONTROLLED PHARMACEUTICAL CONTAINERS MARKET GROWTH SALES REVENUE ANALYSIS 2019-2027

Daily Science | April 09, 2020

news image

In this report, the global Temperature Controlled Pharmaceutical Containers market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2019 to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2019 to 2025. The Temperature Controlled Pharmaceutical Contain...

Read More
news image

Pharmacy Market

ABCELLERA AND EVEREST MEDICINES ANNOUNCE MULTI-TARGET COLLABORATION TO ADVANCE NEW ANTIBODY THERAPIES

Everest Medicines | September 23, 2021

AbCellera and Everest Medicines Limited announced that they have entered into a multi-year collaboration and license agreement to discover therapeutic antibodies for up to 10 targets selected by Everest. The partnership will help to expand Everest’s portfolio of novel medicines across multiple indications, with the initial programs focusing on targets in oncology. We are proud to partner with Everest as they build a robust pipeline of innovative medicines for p...

Read More
news image

Pharma Tech

IKTOS ANNOUNCES DEPLOYMENT OF THEIR AI FOR DRUG DESIGN SOFTWARE MAKYA™ BY CHIESI GROUP

Iktos and Chiesi Group | December 03, 2021

ktos, a company specialized in Artificial Intelligence for new drug design today announced collaboration agreement in AI for new drug design with Chiesi Group, the international research-focused pharmaceutical and healthcare. Under the agreement, Iktos’s de novo generative design software Makya™ will be used by Chiesi scientists to facilitate rapid and cost-effective design of novel compounds and accelerate hit-to-lead/lead optimisation for undisclosed Chiesi’s drug discovery p...

Read More
news image

CLARUS EQUIPS TOP PHARMACEUTICAL COMPANY, ASTRAZENECA, WITH INNOVATIVE THERMOBILE BOARDS IN THE FIGHT AGAINST COVID-19

Clarus | April 22, 2020

Clarus, the industry leader in glassboard innovation and creator of the new TherMobile, a non-porous mobile board that serves as a protective shield during the health screening process, is successfully supporting AstraZeneca's efforts in keeping their essential employees safe while continuing to work during the COVID-19 crisis. "We initially developed TherMobile as a way to keep our own employees safe while implementing employee temperature screening at our facility," said Marc Man...

Read More
news image

TEMPERATURE CONTROLLED PHARMACEUTICAL CONTAINERS MARKET GROWTH SALES REVENUE ANALYSIS 2019-2027

Daily Science | April 09, 2020

In this report, the global Temperature Controlled Pharmaceutical Containers market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2019 to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2019 to 2025. The Temperature Controlled Pharmaceutical Contain...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us